Insider Transactions in Q2 2022 at Insmed Inc (INSM)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2022
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,236
+25.14%
|
-
|
|
May 17
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,996
-2.29%
|
$119,920
$20.18 P/Share
|
|
May 17
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,055
-2.04%
|
$21,100
$20.37 P/Share
|
|
May 17
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,670
-2.37%
|
$33,400
$20.27 P/Share
|
|
May 17
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,022
-1.37%
|
$40,440
$20.34 P/Share
|
|
May 16
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,398
-1.28%
|
$61,164
$18.35 P/Share
|
|
May 16
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
433
-0.83%
|
$7,794
$18.48 P/Share
|
|
May 16
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,114
-1.56%
|
$20,052
$18.41 P/Share
|
|
May 16
2022
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,574
-2.31%
|
$28,332
$18.51 P/Share
|
|
May 16
2022
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,433
-2.55%
|
$25,794
$18.51 P/Share
|
|
May 16
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,394
-0.93%
|
$25,092
$18.45 P/Share
|
|
May 11
2022
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,968
+24.42%
|
-
|
|
May 11
2022
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,137
+26.41%
|
-
|
|
May 11
2022
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,460
+15.53%
|
-
|
|
May 11
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+16.98%
|
-
|
|
May 11
2022
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+21.95%
|
-
|
|
May 11
2022
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
47,598
+15.22%
|
-
|
|
May 11
2022
|
Melvin Md Sharoky Director |
BUY
Open market or private purchase
|
Direct |
20,000
+7.08%
|
$340,000
$17.2 P/Share
|
|
May 11
2022
|
Melvin Md Sharoky Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+5.69%
|
-
|
|
May 11
2022
|
Carol Schafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+31.46%
|
-
|
|
May 11
2022
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+16.79%
|
-
|
|
May 11
2022
|
Leo Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+21.57%
|
-
|
|
May 11
2022
|
Clarissa Desjardins Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+29.15%
|
-
|
|
May 11
2022
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+13.29%
|
-
|
|
May 11
2022
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+25.71%
|
-
|
|
May 11
2022
|
Alfred Altomari Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+25.34%
|
-
|